Epigenetic Change in Kidney Tumor: Downregulation of Histone Acetyltransferase MYST1 in Human Renal Cell Carcinoma

Overview

Journal J Exp Clin Cancer Res

Publisher Biomed Central

Specialty Oncology

Date 2013 Feb 12

PMID 23394073

Citations 34

Authors

Yong Wang

Rui Zhang

Donglu Wu

Zhihua Lu

Wentao Sun

Yong Cai

Chunxi Wang

Jingji Jin

Affiliations

Soon will be listed here.

Abstract

Background: MYST1 (also known as hMOF), a member of the MYST family of histone acetyltransferases (HATs) as an epigenetic mark of active genes, is mainly responsible for histone H4K16 acetylation in the cells. Recent studies have shown that the abnormal gene expression of hMOF is involved in certain primary cancers. Here we examined the involvement of hMOF expression and histone H4K16 acetylation in primary renal cell carcinoma (RCC). Simultaneously, we investigated the correlation between the expression of hMOF and clear cell RCC (ccRCC) biomarker carbohydrase IX (CA9) in RCC.

Materials And Methods: The frozen RCC tissues and RCC cell lines as materials, the reverse transcription polymerase chain reaction (RT-PCR), western blotting and immunohistochemical staining approaches were used.

Results: RT-PCR results indicate that hMOF gene expression levels frequently downregulated in 90.5% of patients (19/21) with RCC. The reduction of hMOF protein in both RCC tissues and RCC cell lines is tightly correlated with acetylation of histone H4K16. In addition, overexpression of CA9 was detected in 100% of ccRCC patients (21/21). However, transient transfection of hMOF in ccRCC 786-0 cells did not affect both the gene and protein expression of CA9.

Conclusion: hMOF as an acetyltransferase of H4K16 might be involved in the pathogenesis of kidney cancer, and this epigenetic changes might be a new CA9-independent RCC diagnostic maker.

Citing Articles

Stabilization of MOF (KAT8) by USP10 promotes esophageal squamous cell carcinoma proliferation and metastasis through epigenetic activation of ANXA2/Wnt signaling.

Li P, Yang L, Park S, Liu F, Li A, Zhu Y Oncogene. 2024; 43(12):899-917.

PMID: 38317006 DOI: 10.1038/s41388-024-02955-z.

The Males Absent on the First (MOF) Mediated Acetylation Alters the Protein Stability and Transcriptional Activity of YY1 in HCT116 Cells.

Wu T, Zhao B, Cai C, Chen Y, Miao Y, Chu J Int J Mol Sci. 2023; 24(10).

PMID: 37240065 PMC: 10217912. DOI: 10.3390/ijms24108719.

NAA60 (HAT4): the newly discovered bi-functional Golgi member of the acetyltransferase family.

Donnarumma F, Tucci V, Ambrosino C, Altucci L, Carafa V Clin Epigenetics. 2022; 14(1):182.

PMID: 36539894 PMC: 9769039. DOI: 10.1186/s13148-022-01402-8.

Clustering of Chromatin Remodeling Enzymes Predicts Prognosis and Clinical Benefit of Therapeutic Strategy in Pancreatic Cancer.

Wang H, Shih H, Wu C, Chen L, Luo C, Liu Y Int J Med Sci. 2022; 19(10):1615-1627.

PMID: 36185333 PMC: 9515693. DOI: 10.7150/ijms.73800.

Two distinct males absent on the first (MOF)-containing histone acetyltransferases are involved in the epithelial-mesenchymal transition in different ways in human cells.

Wei T, Liu H, Zhu H, Chen W, Wu T, Bai Y Cell Mol Life Sci. 2022; 79(5):238.

PMID: 35416545 PMC: 11073432. DOI: 10.1007/s00018-022-04258-6.

References

Rea S, Xouri G, Akhtar A . Males absent on the first (MOF): from flies to humans. Oncogene. 2007; 26(37):5385-94. DOI: 10.1038/sj.onc.1210607. View

Pfister S, Rea S, Taipale M, Mendrzyk F, Straub B, Ittrich C . The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma. Int J Cancer. 2007; 122(6):1207-13. DOI: 10.1002/ijc.23283. View

Cai Y, Jin J, Swanson S, Cole M, Choi S, Florens L . Subunit composition and substrate specificity of a MOF-containing histone acetyltransferase distinct from the male-specific lethal (MSL) complex. J Biol Chem. 2009; 285(7):4268-72. PMC: 2836030. DOI: 10.1074/jbc.C109.087981. View

Janzen N, Kim H, Figlin R, Belldegrun A . Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am. 2003; 30(4):843-52. DOI: 10.1016/s0094-0143(03)00056-9. View

Mosashvilli D, Kahl P, Mertens C, Holzapfel S, Rogenhofer S, Hauser S . Global histone acetylation levels: prognostic relevance in patients with renal cell carcinoma. Cancer Sci. 2010; 101(12):2664-9. PMC: 11159183. DOI: 10.1111/j.1349-7006.2010.01717.x. View

Hussain S, Ganesan R, Reynolds G, Gross L, Stevens A, Pastorek J . Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Br J Cancer. 2007; 96(1):104-9. PMC: 2360224. DOI: 10.1038/sj.bjc.6603530. View

Eichelberg C, Junker K, Ljungberg B, Moch H . Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability. Eur Urol. 2009; 55(4):851-63. DOI: 10.1016/j.eururo.2009.01.003. View

Bhaumik S, Smith E, Shilatifard A . Covalent modifications of histones during development and disease pathogenesis. Nat Struct Mol Biol. 2007; 14(11):1008-16. DOI: 10.1038/nsmb1337. View

Choschzick M, Oosterwijk E, Muller V, Woelber L, Simon R, Moch H . Overexpression of carbonic anhydrase IX (CAIX) is an independent unfavorable prognostic marker in endometrioid ovarian cancer. Virchows Arch. 2011; 459(2):193-200. DOI: 10.1007/s00428-011-1105-y. View

10.

Wu X, Sha J, Liu D, Chen Y, Yang G, Zhang J . High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma. Eur J Surg Oncol. 2012; 39(1):100-6. DOI: 10.1016/j.ejso.2012.10.004. View

11.

Carrozza M, Utley R, Workman J, Cote J . The diverse functions of histone acetyltransferase complexes. Trends Genet. 2003; 19(6):321-9. DOI: 10.1016/S0168-9525(03)00115-X. View

12.

Mendjan S, Taipale M, Kind J, Holz H, Gebhardt P, Schelder M . Nuclear pore components are involved in the transcriptional regulation of dosage compensation in Drosophila. Mol Cell. 2006; 21(6):811-23. DOI: 10.1016/j.molcel.2006.02.007. View

13.

Taipale M, Rea S, Richter K, Vilar A, Lichter P, Imhof A . hMOF histone acetyltransferase is required for histone H4 lysine 16 acetylation in mammalian cells. Mol Cell Biol. 2005; 25(15):6798-810. PMC: 1190338. DOI: 10.1128/MCB.25.15.6798-6810.2005. View

14.

Sykes S, Mellert H, Holbert M, Li K, Marmorstein R, Lane W . Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Mol Cell. 2006; 24(6):841-51. PMC: 1766330. DOI: 10.1016/j.molcel.2006.11.026. View

15.

Leibovich B, Sheinin Y, Lohse C, Thompson R, Cheville J, Zavada J . Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma. J Clin Oncol. 2007; 25(30):4757-64. DOI: 10.1200/JCO.2007.12.1087. View

16.

Swinson D, Jones J, Richardson D, Wykoff C, Turley H, Pastorek J . Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer. J Clin Oncol. 2003; 21(3):473-82. DOI: 10.1200/JCO.2003.11.132. View

17.

Elsheikh S, Green A, Rakha E, Powe D, Ahmed R, Collins H . Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. Cancer Res. 2009; 69(9):3802-9. DOI: 10.1158/0008-5472.CAN-08-3907. View

18.

Orpinell M, Fournier M, Riss A, Nagy Z, Krebs A, Frontini M . The ATAC acetyl transferase complex controls mitotic progression by targeting non-histone substrates. EMBO J. 2010; 29(14):2381-94. PMC: 2910275. DOI: 10.1038/emboj.2010.125. View

19.

Liao S, Aurelio O, Jan K, Zavada J, Stanbridge E . Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney. Cancer Res. 1997; 57(14):2827-31. View

20.

Mulligan P, Yang F, Di Stefano L, Ji J, Ouyang J, Nishikawa J . A SIRT1-LSD1 corepressor complex regulates Notch target gene expression and development. Mol Cell. 2011; 42(5):689-99. PMC: 3119599. DOI: 10.1016/j.molcel.2011.04.020. View